Humacyte News

144: Notice of proposed sale of securities pursuant to Rule 144

May 31 16:58 ET

144: Notice of proposed sale of securities pursuant to Rule 144

May 31 16:33 ET

144: Notice of proposed sale of securities pursuant to Rule 144

May 30 13:58 ET

144: Notice of proposed sale of securities pursuant to Rule 144

May 30 11:18 ET

4: Statement of changes in beneficial ownership of securities-Director Green Charles Bruce

May 21 16:14 ET

4: Statement of changes in beneficial ownership of securities-Director Wallace Max N.

May 21 16:14 ET

4: Statement of changes in beneficial ownership of securities-Director Green Charles Bruce

May 20 16:19 ET

4: Statement of changes in beneficial ownership of securities-Director Binder Gordon M

May 15 19:26 ET

10-Q: Quarterly report

May 13 16:15 ET

8-K: Current report

May 10 07:09 ET

DEFA14A: Others

Apr 29 07:18 ET

DEF 14A: Definitive information statements

Apr 29 07:18 ET

Humacyte | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Mar 28 09:00 ET

Humacyte | 10-K: Annual report

Mar 28 08:09 ET

Humacyte | 8-K: Current report

Mar 22 07:07 ET

Humacyte | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Laura E. Niklason(8.4%),Brady W. Dougan(8.4%), etc.

Mar 8 16:09 ET

Humacyte | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Fresenius Medical Care Holdings, Inc.(15.4%),Fresenius Medical Care AG(15.4%)

Mar 7 15:05 ET

Humacyte | 8-K: Current report

Mar 4 06:55 ET

Humacyte | 424B5: Prospectus

Mar 1 16:13 ET

Humacyte | 424B5: Prospectus

Feb 29 16:16 ET